Global responses to prevent, manage, and control cardiovascular diseases
Table of contents A brief retrospective on GLP-1 In 1932, La Barre and colleagues coined the incretin concept to describe as yet unknown humoral factors released from the intestine that lowered blood glucose in response to a meal
A Plan Just for You: Your provider will look at your family history, your sleep habits, and your stress levels to build a plan that fits your life
In fact, even though sex and gender influence the prevalence, manifestation and progression of, as well as the treatment response to various diseases, progress in biomedical research remains slow in this domain
Meanwhile, findings of a 2021 clinical trial published in JAMA showed that after discontinuing a GLP-1 after 20 weeks, individuals gained back 6.9% of their weight after another 48 weeks